A Bold Vision to Stop Cardiovascular Disease From Being a Leading Cause of Death
At Amarin, we’re focused on stopping cardiovascular disease (CVD) from being a leading cause of death. We believe that CVD patients, their loved ones, and society as a whole deserve a cardiovascular health management option that is reliable and effective in reducing the risk of CVD. There are people throughout the world, now and in the future, relying on us. We can give millions of patients the opportunity to change their lives for the better.
What We Stand For
Who We Serve
What We Do
How We Do It
Get to know Amarin
Who is Amarin? Amarin is a global pharmaceutical company that has developed and is pursuing additional treatments to help address cardiovascular disease. Amarin is relentless in its pursuit of scientific breakthroughs that can lead to revolutionary solutions that create a healthier world. Find out more about who we are, what we stand for and how we are making a difference in the lives of patients.
Find out how Amarin has been creating a new paradigm in cardiovascular disease management for over three decades.
Amarin seeks to collaborate with others to address cardiovascular risk and create value.
A rapidly growing international leader, in the fight to address cardiovascular disease
Amarin focuses on a BOLD vision to stop cardiovascular disease from being a leading cause of death worldwide.
where we are
Our Global Footprint
Our work is about making a positive impact on cardiovascular health across the world. Find out where we're located and how we're making a difference globally.
A BOLD investment in cardiometabolic health
Keeping our investors informed about our progress in helping stop cardiovascular disease from being a leading cause of death is important to us. Click here for our investor presentations, events and financial results.